Trademark: 97036154
Word
IMUNON
Status Date
Tuesday, July 9, 2024
Filing Date
Monday, September 20, 2021
Published for Opposition
Tuesday, May 16, 2023
5 Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer and infectious diseases; biological preparations for the treatment of cancer and infectious diseases; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals and vaccines for the treatment and prevention of cancer
1 Active chemical ingredients for use in the manufacture of pharmaceuticals; chemical, biological, and biochemical preparations for scientific purposes or general industrial manufacturing
42 Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; bioinformatics analysis, namely, DNA analysis services for scientific research purposes; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
Oct 24, 2021
New Application Office Supplied Data Entered
Sep 23, 2021
New Application Entered
Jun 22, 2022
Assigned To Examiner
Jul 1, 2022
Non-Final Action Written
Jul 1, 2022
Non-Final Action E-Mailed
Jul 1, 2022
Notification Of Non-Final Action E-Mailed
Dec 28, 2022
Teas Response To Office Action Received
Dec 28, 2022
Correspondence Received In Law Office
Dec 29, 2022
Teas/Email Correspondence Entered
Jan 11, 2023
Final Refusal Written
Jan 11, 2023
Final Refusal E-Mailed
Jan 11, 2023
Notification Of Final Refusal Emailed
Apr 5, 2023
Examiners Amendment -Written
Apr 5, 2023
Examiners Amendment E-Mailed
Apr 5, 2023
Notification Of Examiners Amendment E-Mailed
Apr 5, 2023
Assigned To Lie
Apr 5, 2023
Examiner's Amendment Entered
Apr 10, 2023
Approved For Pub - Principal Register
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
May 16, 2023
Published For Opposition
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 10, 2024
Sou Teas Extension Received
Jan 10, 2024
Sou Extension 1 Filed
Jan 10, 2024
Sou Extension 1 Granted
Jul 9, 2024
Sou Teas Extension Received
Jul 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Jul 9, 2024
Sou Extension 2 Filed
Jul 9, 2024
Sou Extension 2 Granted
Jan 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
